Amag Pharmaceuticals, Inc.

This study tested a drug called ciraparantag to see if it could quickly reverse the effects of blood thinners in healthy adults. The trial was stopped early and involved 41 participants. The main goal was to measure how well the drug worked using a special blood clotting test.